Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy

BACKGROUND: A commonly employed treatment for advanced staged oropharyngeal squamous cell carcinoma (OPSCC) is concurrent radiation and chemotherapy with cisplatin as the gold standard. Carboplatin is reported to have the same radiopotentiation properties and a superior side effect profile; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Roskies, M., Kay-Rivest, E., Mascarella, M. A., Sultanem, K., Mlynarek, A., Hier, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057223/
https://www.ncbi.nlm.nih.gov/pubmed/27724969
http://dx.doi.org/10.1186/s40463-016-0163-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057223/
https://www.ncbi.nlm.nih.gov/pubmed/27724969
http://dx.doi.org/10.1186/s40463-016-0163-1

Ejemplares similares